Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001732115-18-000001
Filing Date
2018-02-21
Accepted
2018-02-21 12:34:21
Documents
1
Effectiveness Date
2018-02-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7322
  Complete submission text file 0001732115-18-000001.txt   8370
Mailing Address 1452 E. 53RD STREET FL 2 CHICAGO IL 60615
Business Address 1452 E. 53RD STREET FL 2 CHICAGO IL 60615 3122482964
Seurat Therapeutics, Inc. (Filer) CIK: 0001732115 (see all company filings)

EIN.: 814418271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-306108 | Film No.: 18627643